Recombinant human activated protein C for severe sepsis

N Engl J Med. 2001 Jul 19;345(3):219-20; author reply 220-1. doi: 10.1056/NEJM200107193450313.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Fibrinolytic Agents / adverse effects
  • Fibrinolytic Agents / therapeutic use*
  • Hemorrhage / chemically induced
  • Humans
  • Protein C / adverse effects
  • Protein C / therapeutic use*
  • Recombinant Proteins / adverse effects
  • Recombinant Proteins / therapeutic use*
  • Risk
  • Systemic Inflammatory Response Syndrome / drug therapy*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Fibrinolytic Agents
  • Protein C
  • Recombinant Proteins
  • drotrecogin alfa activated